As a Staff Scientist at Thermo Fisher Scientific, Chris leads a cross-functional team developing fluorescent probes, labeling technologies, and cell-based assays focused on immunotherapy research. Over the last fourteen years, he has developed more than seventy novel reagents for characterizing disease on a cellular level in areas such as innate and adaptive immunity, cell growth and proliferation, apoptosis and cytotoxicity, and endocytosis. Currently he is focused on improving the development of cell therapies and therapeutic antibodies.
Mike Hernandez received his PhD from the University of California – Irvine, under the mentorship of Dr. Andrea Tenner. His work investigated the contribution of C5a receptor 1 (C5aR1) to neuroinflammation and neuronal dysfunction in Alzheimer’s Disease, using vitro cell culture studies and mouse models of the disease. Prior to his current role as Technical Sales Specialist for flow cytometry antibodies and reagents, he supported the same portfolio in two different roles: Technical Applications Scientist and Associate Product Manager.
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 100,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.
Thursday, March 3, 2022
12:00 PM - 01:00 PM
Hybrid 2-part Lunch & LearnRegister Now